Clinical Trials Directory

Trials / Sponsors / Proteon Therapeutics

Proteon Therapeutics

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
CompletedSafety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Bel
Peripheral Artery Disease
Phase 12016-11-01
CompletedA Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Crea
Chronic Kidney Disease
Phase 32015-08-01
CompletedA Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patient
Chronic Kidney Disease
Phase 32014-07-01
CompletedPilot Study of PRT-201 Following Angioplasty in Patients With Peripheral Artery Disease (PAD)
Peripheral Artery Disease
Phase 12012-10-01
CompletedA Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidn
Chronic Kidney Disease
Phase 22011-03-01
CompletedA Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disea
Chronic Kidney Disease
Phase 1 / Phase 22009-09-01
CompletedA Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients
Chronic Kidney Disease
Phase 1 / Phase 22008-11-01
WithdrawnSafety/ Feasibility of Percutaneous Administration of Vonapanitase as Monotherapy for Peripheral Artery Diseas
Peripheral Artery Disease
Phase 1—